SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote ()8/18/1999 1:43:00 PM
From: Bo Didley  Read Replies (1) of 5582
 
Patience will reap tremendous rewards.

Accumulate - Accumulate - Accumulate

The common cold is a near $3 billion industry.
Zicam is the number 1 treatment, and will penetrate
the market on an escalating basis, year after year.

Once Zicam has become established in the US, then
it moves internationally. Hopefully to some countries
where their cold season would be reflected in 2nd quarter earnings.

bo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext